open menu

Faculty Scholarship

Faculty Milestones

Our scholars in the world.

       

Raising Concerns: Bob Bloom ’71 was quoted in the Boston Globe about a conflict of interest between police and district attorneys in crime cases. Mary Bilder spoke to Salon about how work to invalidate a supposedly early draft of the Constitution could alter the course of our democracy 200 years later. Jenna Cobb commented on Bloomberg News about the dangerous precedent of permitting an islamophobic lawyer to represent a Muslim client.


Rising to New Heights: Cathleen Kaveny was named a 2023-2024 Phi Beta Kappa Society Visiting Scholar and will travel to 100+ universities next year to participate in their academic communities. Hiba Hafiz was promoted to associate professor with tenure. BC Law added two new faculty to its roster: Sergio J. Campos as a professor and Avlana K. Eisenberg as an associate professor. Legal scholar Lucien Ferguson was named to the 2023-2025 Drinan Scholars Visiting Assistant Professorship.


Following the Cases: Distinguished scholar Mark Brodin discussed the killing of Jordan Neely and the history of vigilantism and racism with ABC News. Health law professor Mary Ann Chirba spoke to STAT news about how it may be difficult to apply Affordable Care Act provisions to Ohio’s Palestine railroad disaster. Patricia McCoy continued to provide perspective regarding the ongoing scrutiny of the banking industry, speaking to the New York Times, ABC News, Bloomberg Law, and scores of others about the Silicon Valley Bank failure and the impact of the bank collapses. She also weighed in with CNN Business and MarketWatch on the sale of First Republic Bank. 


Calling for Experts: The Roosevelt Institute appointed fellowships to two BC Law professors: Hiba Hafiz was named a fellow to help the famed think-tank develop economic and political policies, and visiting professor Beverly Moran was named a senior fellow to provide strategic guidance and expert advice on tax research and advocacy efforts. Diane Ring appeared before the US Senate Finance Committee to discuss the Tax Cuts and Jobs Act and big pharma tax schemes.